Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Investigating the role of Hsf1 in Candida albicans drug resistance and morphogenesis

EF 2015-16

Résumé
Fungal infections caused by Candida albicans are among the leading causes of death in individuals with compromised immune systems. Treatment is challenging due to the emergence of resistance to the limited number of antifungal drugs in clinical use. A key regulator of C. albicans drug resistance is Hsp90, an essential protein that stabilizes many important proteins. Hsp90 also regulates the ability of C. albicans to undergo a morphological transition from a yeast growth state to a filamentous growth state, which is a key virulence trait. Hsp90 inhibition induces filamentation and reduces drug resistance, causing infections that are usually resistant to drugs to be susceptible to treatment. It has recently been found that the transcription factor Hsf1, which regulates the expression of HSP90 and ~3% of the yeast genome, is essential for C. albicans virulence. My research focuses on elucidating the role of Hsf1 in two key virulence traits: drug resistance and morphogenesis. We have found that depletion of Hsf1 has similar effects on drug resistance and morphogenesis as Hsp90 inhibition. Genetic depletion of Hsf1 reduces resistance to echinocandins, a class of antifungal drugs which target the cell wall, and induces filamentation. These effects on drug resistance and morphogenesis were found to be independent of HSP90 expression but may be a result of compromised Hsp90 function. We hypothesize that depletion of Hsf1 affects drug resistance and morphogenesis by modulating the expression of a co-chaperone or other critical regulator of Hsp90, leading to compromised Hsp90 function. Further investigations into the circuitry through which Hsf1 regulates drug resistance and morphogenesis will suggest new targets for treating fungal infections. The development of novel antifungal drugs will greatly impact health care, as it will allow for the treatment of deadly, drug resistant C. albicans infections which are often major problems in hospitals.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
347982
Name
Veri Amanda O
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the role of Hsf1 in Candida albicans drug resistance and morphogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Drug Resistance; Fungal Infections; Infection And Disease; Microbiology; Morphogenesis
Abstract
Fungal infections caused by Candida albicans are among the leading causes of death in individuals with compromised immune systems. Treatment is challenging due to the emergence of resistance to the limited number of antifungal drugs in clinical use. A key regulator of C. albicans drug resistance is Hsp90, an essential protein that stabilizes many important proteins. Hsp90 also regulates the ability of C. albicans to undergo a morphological transition from a yeast growth state to a filamentous growth state, which is a key virulence trait. Hsp90 inhibition induces filamentation and reduces drug resistance, causing infections that are usually resistant to drugs to be susceptible to treatment. It has recently been found that the transcription factor Hsf1, which regulates the expression of HSP90 and ~3% of the yeast genome, is essential for C. albicans virulence. My research focuses on elucidating the role of Hsf1 in two key virulence traits: drug resistance and morphogenesis. We have found that depletion of Hsf1 has similar effects on drug resistance and morphogenesis as Hsp90 inhibition. Genetic depletion of Hsf1 reduces resistance to echinocandins, a class of antifungal drugs which target the cell wall, and induces filamentation. These effects on drug resistance and morphogenesis were found to be independent of HSP90 expression but may be a result of compromised Hsp90 function. We hypothesize that depletion of Hsf1 affects drug resistance and morphogenesis by modulating the expression of a co-chaperone or other critical regulator of Hsp90, leading to compromised Hsp90 function. Further investigations into the circuitry through which Hsf1 regulates drug resistance and morphogenesis will suggest new targets for treating fungal infections. The development of novel antifungal drugs will greatly impact health care, as it will allow for the treatment of deadly, drug resistant C. albicans infections which are often major problems in hospitals.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Veri, Amanda O
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~